journal article·2018-10-31Open access

Rutin–phospholipid complex in polymer matrix for long-term delivery of rutin via skin for the treatment of inflammatory diseases

Bhupen Kalita, Malay K. Das

Abstract

The drug with poor oral bioavailability necessitates the development of novel carrier for efficient drug delivery. This paper reports the rutin-phospholipid complex in polymer matrix for sustained delivery of rutin via the skin for the treatment of acute and chronic inflammatory diseases. Rutin in phospholipid complex (RNPs) are better soluble and permeable than the free rutin. The RNPs-loaded polymeric matrix patch with moderate adhesiveness was developed for convenient means of long term drug application on the skin. The patch was analysed for physicochemical properties, ex vivo skin permeability and in vivo efficacy in rat paw oedema model. The skin targeting efficacy was analysed by CLSM study. Optimized formulation (F2) showed 31 ± 2.32% and 26.56 ± 5.52% skin permeation at 24 h across excised rat skin and human cadaver skin, respectively. The sustained anti-inflammatory effect of the patch formulation in rat paw oedema model confirmed its unique in vivo efficacy over the conventional diclofenac gel. The CLSM study confirmed the localization of RNPs in the dermis for sustained anti-inflammatory effect. Our results suggest that the developed patch has a potential for long term site specific delivery of rutin in arthritic patients.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Bee Products Chemical Analysis · Essential Oils and Antimicrobial Activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, Dibrugarh University

Girijananda Chowdhury Institute of Pharmaceutical Science

References (79)

Show source-provided references
1. 10.1007/BF0057016110.1007/BF00570161 ↗
2. 10.1111/j.1526-4637.2010.00809.x10.1111/j.1526-4637.2010.00809.x ↗
3. 10.3810/pgm.2009.03.198610.3810/pgm.2009.03.1986 ↗
4. 10.1080/00325481.2013.111056701110.1080/00325481.2013.1110567011 ↗
5. 10.5435/JAAOS-21-09-57710.5435/JAAOS-21-09-577 ↗
6. 10.1111/pme.1228810.1111/pme.12288 ↗
7. National Institute for Health and Clinical Excellence. NICE clinical guideline 59. The care and management of osteoarthritis in adults. 2008.
8. 10.1002/acr.2159610.1002/acr.21596 ↗
9. 10.3899/jrheum.09093510.3899/jrheum.090935 ↗
10. 10.1186/1472-6882-11-11010.1186/1472-6882-11-110 ↗
11. 10.1016/j.intimp.2008.11.00210.1016/j.intimp.2008.11.002 ↗
12. 10.1080/10826076.2011.55568710.1080/10826076.2011.555687 ↗
13. 10.1016/j.jep.2007.05.01210.1016/j.jep.2007.05.012 ↗
14. 10.1016/S0014-827X(01)01111-910.1016/S0014-827X(01)01111-9 ↗
15. 10.1016/j.abb.2014.05.01610.1016/j.abb.2014.05.016 ↗
16. 10.1016/j.jss.2013.12.02810.1016/j.jss.2013.12.028 ↗
17. 10.1186/ar237210.1186/ar2372 ↗
18. 10.1177/096032711351233710.1177/0960327113512337 ↗
19. 10.3831/KPI.2017.20.00310.3831/KPI.2017.20.003 ↗
20. 10.1016/S0099-5428(08)60177-X10.1016/S0099-5428(08)60177-X ↗
21. 10.1002/biof.552012012710.1002/biof.5520120127 ↗
22. Yang C-Y, Hsiu S-L, Wen K-C, et al. Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J Food Drug Anal. 2005;13:244–250.
23. 10.1016/S0304-3835(97)04644-210.1016/S0304-3835(97)04644-2 ↗
24. 10.1007/s00228000019710.1007/s002280000197 ↗
25. 10.1177/0091270012201036610.1177/00912700122010366 ↗
26. 10.1007/s40005-013-0084-110.1007/s40005-013-0084-1 ↗
27. 10.1038/nm0295-15410.1038/nm0295-154 ↗
28. 10.7324/JAPS.2014.40101010.7324/JAPS.2014.401010 ↗
29. Kalita B, Das MK, Sarma M, et al. Skin targeted delivery of rutin-phospholipid complex: patch formulation, in vitro-in vivo evaluation. World J Pharm Sci. 2015;3:2042–2057.
30. 10.1055/s-2006-96042010.1055/s-2006-960420 ↗
31. Chaudhari P, Sharma P, Barhate N, et al. Solubility enhancement of hydrophobic drugs using synergistically interacting cyclodextrins and cosolvent. Current Sci 2007;92:1586–1591.
32. 10.1016/j.chroma.2004.01.00110.1016/j.chroma.2004.01.001 ↗
33. Appa Rao B, Shivalingam MR, Kishore Reddy YV, et al. Formulation and evaluation of aceclofenac solid dispersions for dissolution rate enhancement. Int J Pharm Sci Drug Res. 2010;2:146–150.
34. 10.3109/10731199.2011.63792410.3109/10731199.2011.637924 ↗
35. 10.1081/DDC-12001667810.1081/DDC-120016678 ↗
36. Mehdzadeha A, Toliate T, Rouini MR, et al. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches. Acta Pharm. 2004;54:301–317.
37. 10.1517/17425247.2012.63710710.1517/17425247.2012.637107 ↗
38. 10.12991/mpj.201519861210.12991/mpj.2015198612 ↗
39. 10.1016/j.jsps.2011.08.00110.1016/j.jsps.2011.08.001 ↗
40. 10.1023/B:JTAN.0000038989.28709.7f10.1023/B:JTAN.0000038989.28709.7f ↗
41. 10.1155/2011/41831610.1155/2011/418316 ↗
42. 10.1208/pt080411110.1208/pt0804111 ↗
43. Soujanya C, Lakshmi SB, Lokesh RM, et al. Formulation and in vitro and in vivo evaluation of transdermal patches of lornoxicam using natural permeation enhancers. Int J Pharm Pharm Sci. 2014;6:282–286.
44. 10.1248/bpb.b14-0001510.1248/bpb.b14-00015 ↗
45. 10.7439/ijbr.v4i10.39810.7439/ijbr.v4i10.398 ↗
46. Rasaie S, Ghanbarzadeh S, Mohammadi M, et al. Nano phytosomes of quercetin: a promising formulation for fortification of food products with antioxidants. Pharma Sci. 2014;20:96–101.
47. Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J Appl Pharm Sci. 2012;2:129–138.
48. 10.1208/s12249-011-9584-310.1208/s12249-011-9584-3 ↗
49. 10.4103/0250-474X.4034010.4103/0250-474X.40340 ↗
50. Panchagnula R. Transdermal delivery of drugs. Ind J Pharmacol. 1997;29:140–156.
51. 10.4161/derm.1.4.950110.4161/derm.1.4.9501 ↗
52. 10.1038/aps.2009.18610.1038/aps.2009.186 ↗
53. Mamatha T, Venkateswara RJ, Mukkanti K, et al. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in vitro characterization. DARU. 2010;18:9–16.
54. 10.3109/0363904970915076310.3109/03639049709150763 ↗
55. 10.1208/pt080203910.1208/pt0802039 ↗
56. Gantner DC Schalau IIGK Thomas X. (2015). Soft skin adhesive gels and liners: new formulating options for tailored solutions. In: DOW CORNING. Available from: http://www.dowcorning.com/content/publishedlit/52-1113.pdf
57. 10.1111/jphp.1259410.1111/jphp.12594 ↗
58. 10.1016/j.jsps.2014.11.00110.1016/j.jsps.2014.11.001 ↗
59. Zaveri M, Gajjar H, Kanaki N, et al. Preparation and evaluation of drug phospholipid complex for increasing transdermal penetration of phytoconstituents. Int J Institutional Pharm Life Sci. 2011;1:80–93.
60. Yun-shu M, Hao-ru Z, Yi-ning L. Studies on permeation of Puerarin and its phospholipid complex through rat skin in vitro. Chin J Chin Mat Med. 2000;25:274–276.
61. 10.1007/s12272-011-0405-810.1007/s12272-011-0405-8 ↗
62. Singh RP, Narke R. Preparation and evaluation of phytosomes of Lawsone. Int J Pharm Sci Res. 2015;6:5217–5226.
63. 10.1186/s13065-017-0254-810.1186/s13065-017-0254-8 ↗
64. 10.1016/j.ijpharm.2017.07.06210.1016/j.ijpharm.2017.07.062 ↗
65. 10.22159/ijpps.2017v9i1.1463510.22159/ijpps.2017v9i1.14635 ↗
66. Jun Y, Pingping W, Xiaojin C, et al. Study on transdermal permeation and skin accumulation of diammonium glycyrrhizinate vesicular carriers. Chin J Modern Appl Pharm. 2013;30:977–980.
67. Pereira A, Mallya R. Formulation and evaluation of a photoprotectant cream containing Phyllanthus emblica extract phospholipid complex. J Pharmacog Phytochem. 2015;4:232–240.
68. 10.1016/j.addr.2007.07.00410.1016/j.addr.2007.07.004 ↗
69. 10.1016/j.ejps.2012.04.02410.1016/j.ejps.2012.04.024 ↗
70. 10.1002/jps.1020010.1002/jps.10200 ↗
71. 10.1111/jphp.1228010.1111/jphp.12280 ↗
72. Tripathy S, Das MK. Curcumin-phospholipid supramolecular complex for transdermal application. Der Pharm Lett. 2013;5:224–233.
73. 10.1016/S0928-0987(98)00037-210.1016/S0928-0987(98)00037-2 ↗
74. 10.1023/A:101210932963110.1023/A:1012109329631 ↗
75. 10.1023/A:100751032334410.1023/A:1007510323344 ↗
76. 10.1590/S1516-9332200200010000510.1590/S1516-93322002000100005 ↗
77. Rajesh K, Murugesan SK. Development of protransferrosomal system for effective transdermal delivery of nifedipine. World J Pharm Pharmaceut Sci. 2014;3:604–623.
78. 10.2147/IJN.S8278810.2147/IJN.S82788 ↗
79. 10.2147/IJN.S4674810.2147/IJN.S46748 ↗